Core Viewpoint - The company reported a revenue of HKD 117 million for the six months ending June 30, 2025, representing a year-on-year decrease of 0.44% and a net loss of HKD 7.535 million compared to a profit of HKD 7.483 million in the same period last year [1] Financial Performance - Revenue for the period was HKD 117 million, down 0.44% year-on-year [1] - The company incurred a net loss of HKD 7.535 million, contrasting with a profit of HKD 7.483 million in the previous year [1] - Basic loss per share was HKD 0.0565 [1] Cost Analysis - The decline in profit was primarily attributed to a decrease in gross profit during the reporting period [1] - Increased advertising and promotional expenses, including online and offline advertising as well as hiring of artists and KOLs, contributed to the financial downturn [1] - Employee costs rose due to increases in salaries, allowances, and other benefits, along with a higher number of employees [1]

Core Viewpoint - The company reported a revenue decrease of approximately 0.4% for the first half of 2025, amounting to about 117.3 million HKD compared to the same period in 2024 [1] Financial Performance - Gross profit declined by approximately 5.5%, from about 87.4 million HKD in the first half of 2024 to about 82.6 million HKD in the first half of 2025 [1] - Overall gross margin decreased by 3.7 percentage points, from 74.2% in the first half of 2024 to 70.5% in the first half of 2025 [1] - The company recorded a net loss of approximately 7.5 million HKD for the first half of 2025, contrasting with a net profit of approximately 7.5 million HKD in the first half of 2024 [1]

Financial Performance - Revenue decreased by approximately 0.4% from about HKD 117.8 million in the first half of 2024 to about HKD 117.3 million in the first half of 2025[2] - Gross profit fell by approximately 5.5% from about HKD 87.4 million in the first half of 2024 to about HKD 82.6 million in the first half of 2025, with a gross profit margin decline of 3.7 percentage points to 70.5%[2] - The group recorded a net loss of approximately HKD 7.5 million in the first half of 2025, compared to a net profit of approximately HKD 7.5 million in the first half of 2024[2] - Total revenue for the six months ended June 30, 2025, was HKD 117,292,000, slightly down from HKD 117,811,000 in the same period of 2024, representing a decrease of 0.44%[12] - Retail business revenue increased to HKD 71,484,000 in 2025 from HKD 69,035,000 in 2024, marking a growth of 3.54%[12] - The basic and diluted loss per share for the first half of 2025 was HKD 5.65, compared to earnings per share of HKD 7.48 for the first half of 2024[3] - Basic loss per share for the six months ended June 30, 2025, was HKD 0.0564, compared to a profit of HKD 0.0748 per share in 2024[23] Dividend and Shareholder Returns - The board does not recommend the payment of an interim dividend for the six months ending June 30, 2025, compared to HKD 30 million for the same period in 2024[2] - The interim dividend declared for the six months ended June 30, 2024, amounted to HKD 30,000,000[34] - The company approved and paid a final dividend of HKD 20,000,000 for the previous fiscal year during the interim period[35] Assets and Liabilities - Total assets decreased from HKD 197.5 million as of December 31, 2024, to HKD 174.7 million as of June 30, 2025[4] - Current liabilities increased slightly from HKD 37.5 million as of December 31, 2024, to HKD 37.8 million as of June 30, 2025[4] - Non-current assets decreased from HKD 44.5 million as of December 31, 2024, to HKD 34.4 million as of June 30, 2025[4] - Cash and cash equivalents decreased from HKD 119.2 million as of December 31, 2024, to HKD 89.8 million as of June 30, 2025[4] - Trade receivables, net of loss provisions, decreased to HKD 25,242,000 as of June 30, 2025, from HKD 26,293,000 as of December 31, 2024, a decline of 4%[29] - Trade payables increased to HKD 4,677,000 as of June 30, 2025, compared to HKD 3,782,000 as of December 31, 2024, an increase of 23.6%[32] - Cash and cash equivalents stood at HKD 89,755,000 as of June 30, 2025, down from HKD 119,215,000 as of December 31, 2024, representing a decrease of 24.7%[31] Operational Costs - Employee costs increased to HKD 43,506,000 in 2025 from HKD 34,787,000 in 2024, reflecting a rise of 25.00%[19] - Depreciation expenses for property, plant, and equipment amounted to HKD 10,771,000 in 2025, up from HKD 9,682,000 in 2024, an increase of 11.25%[20] - Sales and distribution costs increased by approximately HKD 17.4 million or 35.3% in the first half of 2025, primarily due to increased advertising and promotional expenses related to new products and brand development[48] - Administrative and other operating expenses rose by approximately HKD 8.1 million or 43.8% in the first half of 2025, mainly due to increased employee costs and higher depreciation from an increase in the average number of self-operated retail stores from 26 to 33[49] - Financing costs increased by approximately HKD 104,000 or 21.7% to about HKD 583,000 in the first half of 2025, attributed to higher interest expenses from lease liabilities due to an increase in the average number of self-operated retail stores[51] Inventory and Impairment - The inventory of health and beauty products increased to HKD 33,883,000 as of June 30, 2025, compared to HKD 22,992,000 as of December 31, 2024, reflecting a growth of 47.5%[28] - The company recognized an impairment loss of HKD 1,036,000 for certain underperforming retail stores in 2025, compared to no impairment loss in 2024[27] - The provision for obsolete inventory decreased to HKD 59,000 as of June 30, 2025, from HKD 126,000 as of December 31, 2024[28] Capital Expenditures and Funding - Capital expenditures in the first half of 2025 were approximately HKD 0.2 million, a significant decrease from approximately HKD 3.2 million in the first half of 2024, with future capital expenditures expected to increase as business grows[59] - The company raised approximately HKD 125,001,000 from the issuance of 33,333,600 new ordinary shares at an issue price of HKD 3.75 per share[37] - The net proceeds from the global issuance of 33,333,600 shares at HKD 3.75 per share amounted to approximately HKD 94.4 million after deducting underwriting fees and other expenses[76] - The planned use of net proceeds includes 35.7% for marketing and promotional activities to enhance brand recognition, totaling approximately HKD 33.7 million[77] - 37.8% of the proceeds, approximately HKD 35.7 million, is allocated for expanding and optimizing the sales network[77] - 12.4% of the proceeds, approximately HKD 11.7 million, is designated for talent recruitment[77] - The total amount of net proceeds utilized as of the reporting period was HKD 18.3 million, leaving HKD 76.1 million unutilized[77] Corporate Governance and Compliance - The audit committee consists of three independent non-executive directors, ensuring proper oversight of financial reporting and internal controls[80] - The interim financial report for the six months ending June 30, 2025, has been reviewed by an independent auditor in accordance with Hong Kong standards[81] - The interim results announcement and report will be published on the company's website and the Hong Kong Stock Exchange website[82] - The company has maintained sufficient public float as per listing rules during the reporting period and up to the announcement date[74] Future Outlook - The group plans to continue product innovation and development, focusing on launching the product "Herbs Tiger Milk Cough Relief" and the new brand "MedHerbs" in the second half of 2025[40] - The group operates nine proprietary brands as of June 30, 2025, including "Herbs," "ZINO," and "MedHerbs"[38] - The group confirmed the recognition of all revenue upon customer ownership and acceptance of products, adhering to HKFRS 15[12] - The group had no significant contingent liabilities as of June 30, 2025, and December 31, 2024[61] - No significant investments or plans for major acquisitions or disposals of subsidiaries, joint ventures, or associates were reported for the first half of 2025[65][66]

Group 1 - The board meeting of Grass Ji Group (02593.HK) is scheduled for August 28, 2025, to approve the unaudited interim results for the six months ending June 30, 2025 [1] - The meeting will also consider whether to recommend the distribution of an interim dividend, if applicable [1]

Herbs Generation Group Holdings Limited 草姬集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2593） 董事會會議日期 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 草 姬 集 團 控 股 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，董 事 會 會 議 將 於 二 零 二 五 年 八 月 二 十 八 日（星 期 四）舉 行，藉 以（其 中 包 括）批 准 本 公 司 及 其 附 屬公司截至二零二五年六月三十日止六個月之未經審核中期業績公告及其發 佈，以 及 考 慮 會 否 建 議 派 發 中 期 股 息（如 有）。 承董事會命 草姬集團控股有限公司 董事會主席兼執行董事 郭致因 香 港，二 零 二 五 年 八 月 十 八 日 於 本 公 告 日 期，董 事 會 由(i)執 行 董 事 郭 致 因 女 士、李 日 勝 ...

Core Viewpoint - The company anticipates a net loss of approximately HKD 7 million to HKD 8 million for the six months ending June 30, 2025, a significant decline from a net profit of HKD 7.5 million for the same period in 2024 [1] Summary by Relevant Categories Financial Performance - The expected net loss for the upcoming period is projected to be between HKD 7 million and HKD 8 million, contrasting with a net profit of HKD 7.5 million in the previous year [1] Factors Influencing Performance - The decline in gross profit during the reporting period is attributed to an increase in promotional discounts [1] - There has been a rise in advertising and promotional expenses, which includes online and offline advertising as well as hiring artists and KOLs [1] - Employee costs have increased due to higher salaries, wages, and other benefits [1]

Core Viewpoint - The company, 草姬集团, anticipates a net loss of approximately HKD 7 million to HKD 8 million for the six months ending June 30, 2025, a significant decline from a net profit of HKD 7.5 million for the same period in 2024 [1] Summary by Relevant Categories Financial Performance - The expected net loss for the upcoming period is projected to be between HKD 7 million and HKD 8 million [1] - This represents a shift from a net profit of HKD 7.5 million recorded for the six months ending June 30, 2024 [1] Factors Contributing to Performance - The decline in gross profit during the reporting period is attributed to an increase in promotional discounts [1] - There has been a rise in advertising and promotional expenses, which includes online and offline advertising as well as hiring artists and KOLs [1] - Employee costs have increased due to higher salaries, wages, and other benefits [1]

草姬集团(02593)公布，该集团预期截至2025年6月30日止六个月的亏损净额将约为700万港元至800万港 元，相比2024年6月30日止六个月净利润为750万港元。该变动主要由于：集团于报告期间的毛利下降， 主要由于报告期间促销优惠增加;于报告期间广告及推广开支上升(包括但不限于线上广告、线下广告以 及委聘艺人及KOL);及员工成本增加，主要由于薪金、工资及其他福利的增长。 ...

Herbs Generation Group Holdings Limited 草姬集團控股有限公司 （於開曼群島註冊成立的有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 董事會主席兼執行董事 郭致因 （股份代號：2593） 盈利警告 本 公 告 乃 由 草 姬 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」） 根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」）第13.09條及香港法例 第571章證券及期貨條例第XIVA部 之 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 作 出。 本 公 司 董 事（「董 事」）會（「董事會」）謹 此 告 知 本 公 司 股 東 及 潛 在 投 資 者，根 據 對 本 集 團 所 得 最 新 財 務 資 料 進 行 之 初 步 評 估，本 集 團 預 期 截 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 草姬集團控股有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02593 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本 ...